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Abstract 
Recently it was shown explicitly that free recall consists of two stages: the first few recalls empty working 
memory (narrowly defined) and a second stage, a reactivation stage, concludes the recall (Tarnow, 2015; 
for a review of the theoretical predictions see Murdock, 1974). It was also shown that the serial position 
curve changes in mild Alzheimer’s disease – lowered total recall and lessened primacy - are similar to 
second stage recall and different from recall from working memory. 
The Tarnow Unchunkable Test (TUT, Tarnow, 2013) uses double integer items to separate out only the 
first stage, the emptying of working memory, by making it difficult to reactivate items due to the lack of 
intra-item relationships.   
Here it is shown that subject TUT selects out diagnosed Alzheimer’s Disease but not MCI. On average, 
diagnosed Alzheimer’s Disease is correlated with a loss of 0.7 memory slots (out of an average of 2.7 
slots). 
The identification of a lost memory slot may have implications for improved stage definitions of 
Alzheimer’s disease and for remediation therapy via working memory capacity management.  In 
conjunction with the Alzheimer’s disease process map, it may also be useful to identify the exact location 
of working memory. 
                                                 
1 The author is an independent researcher.  He received a PhD in physics from MIT.  His research areas 
include short term memory, conformity, obedience, dreams, marketing science, management science, 
and semiconductor physics. 
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Introduction 
Free recall, in which items in a list are displayed or read to subjects who are then asked to retrieve the 
items, is one of the simplest ways to probe short term memory. It is used in neuropsychological batteries 
to test for the presence of Alzheimer’s disease, for example, MMSE, ADAS-Cog, FREES, CVLT, DWR, 
etc (for a review see Cullen et al, 2007).  The corresponding serial position curve, the probability of 
recalling an item versus the order in which the item was presented, is u-shaped: items in the beginning of 
the presented list (primacy) and at the end of the list (recency) are more likely to be recalled than those in 
the middle of the list.  
It was recently shown explicitly that free recall is a well defined two stage process (Tarnow, 2015; this had 
been suggested before, for a review see Murdock, 1974).  In the first stage working memory is emptied 
and in the second stage a different retrieval process occurs using reactivation of items.  Working memory 
is responsible for recency (and some primacy for short lists) and the second stage recall shows some 
primacy but no recency.  Bayley et al (2000) found that a reduction in the primacy effect is an early and 
ubiquitous feature of the memory impairment of AD and Tarnow (2016) showed that early Alzheimer’s 
disease correlates with a loss of items from the second stage. In this contribution we explore what 
happens to the first stage in MCI and diagnosed Alzheimer’s disease. 
Method 
Subjects 
Participants (see Table 1) were part of a clinical study for aging and dementia at the Alzheimer’s Disease 
Research Center at Icahn School of Medicine at Mount Sinai (ADRC ISMMS).  Inclusion criteria included 
65 years of age or older, primarily English/Chinese/Spanish speaking, visual and auditory acuity 
adequate for cognitive testing, willingness to participate in all clinical assessment, and having a study 
partner available as an informant.   
Study procedure 
All participants were asked to complete a 3-hour in-person dementia evaluation, which consisted of 
recording of demographic information, clinical interview, cognitive evaluation, medical examination, and 
functional assessment.  Upon completion of the evaluation, all participants were assigned a research 
diagnosis of normal cognition, Mild Cognitive Impairment (MCI), and dementia using Clinical Research 
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Diagnostic Criteria employed at the ADRC ISMMS.  The study was approved by the institutional board of 
the ISMMS.  All participants provided signed informed consent.    
Records indicating dementia due to oncology treatment and due to vascular dementia were discarded as 
was a record of a subject who refused to answer more than once. 
DX 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Normal 83 62.9 63.8 63.8 
MCI 37 28.0 28.5 92.3 
AD 10 7.6 7.7 100.0 
Total 130 98.5 100.0  
Missing System 2 1.5   
Total 132 100.0   
 
Table 1.  Breakdown of study subjects. 
 
 
The Tarnow Unchunkable Test (TUT, Tarnow, 2013) attempts to separate out just the first stage of free 
recall which empties working memory.  It uses particular double-digit combinations which lack intra-item 
relationships, minimizing inter-item associative strengths (Deese, 1959), so that the second reactivation 
stage does not occur.   The TUT is copyrighted and patent pending and can be purchased from Tarnow.  
It consists of 3-item tests and 4-item tests and can be done using paper, as was the case in this article, or 
computer.  It has been used on 193 Russian college students (Ershova & Tarnow, 2016). The time to 
administer the 3 item test by itself is a couple of minutes. 
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Results 
The main results will center on the 3 item memory score.   
The properties of the different cultures of the normal subjects are shown in Table 2. The 3 and 4 item 
memory tests are culture independent.  In the subject sample age and gender are rather evenly 
distributed among the cultures. The only cultural dependency we find is the educational level which is 
highest for English and Mandarin and lower for Cantonese and then for Spanish. 
Table 2.  ANOVA of the language groups show language independence of the TUT 3 and 4 item 
memory tests for normal subjects.  Educational level was significantly dependent upon the 
language. 
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In Table 3 is shown that the 3 item memory and 4 item memory tests are not correlated with 
gender.  In Table 4 is shown that the TUT tests do not correlate with age or education.  In 
addition the 3 and 4 item tests are not strongly correlated.  It was found elsewhere (Ershova & 
Tarnow, 2016) that it is because the 4 item test exceeds the capacity of most subjects’ working 
memory and the subjects do not manage their working memory efficiently under those 
circumstances with a resulting large distribution of scores.  
 
 
Table 3.  ANOVA test for Gender. 
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Adjusted R squared TUT: 3 item TUT: 4 item 
Age -0.006 -0.012 
Education 0.033 0.062 
TUT: 3 item  .168 
TUT: 4 item   
Table 4.  Regression shows the test results for normal subjects are independent of age and 
education and within the test only the TUT: 3 and 4-item tests are somewhat correlated. 
 
In contrast, statistical tests on the AD population versus the others (normal and MCI) (see Table 
5) show that the 3 item memory is strongly correlated with the AD diagnosis; age is as well.  The 
AD population average is 0.7 items below the normal population (Table 6).  Statistical tests on 
the MCI population (Table 7) shows that neither the 3 item memory or the 4 item memory are 
correlated with the MCI diagnosis. 
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Table 5. ANOVA distinguishing AD diagnosed subjects from remaining subjects. 
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Table 6.  Average scores on 3 item test for the different diagnostic categories.  The difference 
between AD and Normals is 0.7 items. 
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Table 7. ANOVA distinguishing MCI from remaining subjects.  
The serial position curves for the normal and AD populations for the 3 item test are shown in Fig. 
1.  They show primacy and no recency (also in Ershova & Tarnow, 2016).  The first item is not 
very affected by AD but the second and third items are much less likely to be recalled.  
 
Fig. 1.  Serial position curves for 3 item test.  
Total recall distributions for the 3 item tests is shown in Fig. 2.  The distribution for MCI is similar to 
normal while the distribution for AD subjects is moved towards lower values.  The corresponding ROC 
curve is shown in Fig. 4 and the area under the curve is 0.78.  Fig. 5 shows how much the 3 item score 
increases the odds of an AD diagnosis in the current subject population.   
Total recall distributions for the 4 item tests is shown in Fig. 6.  The distributions are much wider (also in 
Ershova & Tarnow, 2016) which presumably explains why it is not sensitive to AD even though the serial 
position curves show similar differences between AD and normal subjects (Fig. 7). 
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Figure 2.  Histograms for 3 item memory. 
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Figure 3. ROC area under curve for AD diagnostic stage=0.78. 
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Fig. 4. Probability that a subject coming to the clinic will have AD as a function of the TUT 3 item recall. 
 
Fig. 5.  Serial position curves for 3 item test for normal and MCI subjects. 
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Fig 6. Histograms of TUT 4-item memory recalls. 
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Fig. 7. Serial position curves of normal and AD subjects for the TUT 4-item test. 
 
Fig. 8. Serial position curves of normal and MCI subjects for the TUT 4-item test. 
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Discussion 
The results show that the first stage of free recall as measured by the TUT 3 item test is not affected by 
MCI but by an AD diagnosis.  Damage to the second stage of free recall occurs in early AD (Tarnow, 
2015) and damage to the first stage of recall occurs in diagnosed AD.   
The finding that AD results in the loss of working memory may be important for remediation therapy, 
though working memory capacity management has yet to be tried on a large population.  But perhaps 
now is the time (this was argued to be important for a population of college students as well in Ershova & 
Tarnow, 2016).   
The size of working memory may also be a measure of drug efficacy: if AD working memory changes can 
be prevented or reversed, then the drug may prevent or reverse the AD stage. 
It could also be that the loss of working memory may be a good diagnostic milestone since it is well 
defined.  It presumably corresponds to a stage in the Braak & Braak (1995) observations. 
That the TUT displays language independency would suggest that it is a good test to use on multicultural 
populations.  It also displays independency of age and education, further properties that are important for 
testing populations for physical diseases like Alzheimer’s disease that may be in part hidden by aging or 
educational attainments. 
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